OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD26/DPP4 - a potential biomarker and target for cancer therapy
Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester, et al.
Pharmacology & Therapeutics (2019) Vol. 198, pp. 135-159
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

Dipeptidylpeptidase‐4‐targeted activatable fluorescent probes visualize senescent cells
Hisamichi Tanaka, Sho Sugawara, Yôko Tanaka, et al.
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2762-2773
Open Access | Times Cited: 4

The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review
Anoosha Niazmand, Reza Nedaeinia, Nasimeh Vatandoost, et al.
Gene (2024) Vol. 927, pp. 148659-148659
Open Access | Times Cited: 4

Harnessing cell-surface CD26 proteolysis-targeting chimeras for molecular targeted therapy against non-small cell lung cancer
Qiuyu Gong, Guangjian Zhang, Bohao Liu, et al.
Research Square (Research Square) (2025)
Closed Access

Development and Validation of a Non-Invasive Prediction Model for Glioma-Associated Epilepsy: A Comparative Analysis of Nomogram and Decision Tree
Zhandong Don Zhong, Hong-Fei Yu, Yanfei Tong, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1111-1125
Open Access

HSPB1 suppresses oxLDL-induced vascular smooth muscle cell ferroptosis by inhibiting DPP4
Yi Li, Lijun Zhang, Qi Zhang, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110400-110400
Closed Access

Incretin-Based Therapies and Cancer: What’s New?
Sanja Medenica, Jelena Bogdanović, Jelena Vekić, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 678-678
Open Access

Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+cancer stem cells subsets
Lorena Vázquez‐Iglesias, Leticia Barcia-Castro, Marta Rodríguez‐Quiroga, et al.
Biology Open (2019)
Open Access | Times Cited: 32

A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2
Cecy Xi, Arianna Di Fazio, Naveed A. Nadvi, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5392-5392
Open Access | Times Cited: 28

Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
Zhuohui Chen, Tong Wu, Zhouyi Yan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26

Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
Karim Chouchane, Giovanni Di Zenzo, Dario Pitocco, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25

Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
Emile Verhulst, Delphine Garnier, Ingrid De Meester, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 624-624
Open Access | Times Cited: 16

Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4
Xiarong Hu, Qingyao Ye, HuanQuan Lu, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3

DPP8 is a novel therapeutic target for multiple myeloma
Tsutomu Sato, Ayumi Tatekoshi, Kohichi Takada, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 28

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
Tingting Shi, Hisakazu Iwama, Koji Fujita, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13071-13071
Open Access | Times Cited: 23

Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer
Yanliang Liu, Fengqin Guo, Wenyi Guo, et al.
Clinical and Experimental Medicine (2021) Vol. 21, Iss. 3, pp. 467-477
Closed Access | Times Cited: 22

EVIDENCE FOR BIOLOGICAL AGE ACCELERATION AND TELOMERE SHORTENING IN COVID19 SURVIVORS
Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22

Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma
Zhuolun Sun, Tengcheng Li, Chutian Xiao, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15

Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway
Qingyuan He, Hongxin Cao, Yuelei Zhao, et al.
Thyroid (2022) Vol. 32, Iss. 11, pp. 1411-1422
Closed Access | Times Cited: 15

Metformin as a promising target for DPP4 expression: computational modeling and experimental validation
Amr Ahmed El‐Arabey, Haiyan Zhang, Mohnad Abdalla, et al.
Medical Oncology (2023) Vol. 40, Iss. 10
Open Access | Times Cited: 8

Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
Shaolan Li, Fan Yang, Asako Kumagai, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 805-805
Open Access | Times Cited: 23

A novel chimeric antigen receptor redirecting T-cell specificity towards CD26+ cancer cells
Shu Zhou, Weiming Li, Yi Xiao, et al.
Leukemia (2020) Vol. 35, Iss. 1, pp. 119-129
Closed Access | Times Cited: 23

Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects
Belgin Sever, Hasan Soybir, Şennur Görgülü, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5003-5003
Open Access | Times Cited: 21

Vildagliptin‐Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9‐Specific Lead
Siham Benramdane, Joni De Loose, Olivier Beyens, et al.
ChemMedChem (2022) Vol. 17, Iss. 15
Closed Access | Times Cited: 13

Scroll to top